Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12016913 Immunogenic compositions and uses thereof

Patent 12016913 was granted and assigned to Pfizer on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Cindy Xudong Yang0

Lei Hu0

Annaliesa Sybil Anderson0

Avvari Krishna Prasad0

Amardeep Singh Bhupender Bhalla0

Miguel Angel Garcia0

Leena Shriram Bagle0

Lakshmi Khandke0

Date of Patent

June 25, 2024

0

Patent Application Number

174745610

Date Filed

September 14, 2021

0

Patent Citations

US Patent 7384640 Mutant cholera holotoxin as an adjuvant

0

US Patent 8652480 Shortened purification process for the production of capsular

0

US Patent 10226525 Group B

0

US Patent 10751402 Immunogenic compositions and uses thereof

0

US Patent 11147865 Immunogenic compositions and uses thereof

0

US Patent 10946086 Group B

0

US Patent 7115730 Immunogenic detoxified mutant

0

US Patent 7285281 Mutant forms of cholera holotoxin as an adjuvant

0

...

Patent Primary Examiner

Jennifer E. Graser

0

Patent abstract

The invention relates to immunogenic compositions comprising a capsular polysaccharide (CP) from

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12016913 Immunogenic compositions and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool